TEMOZOLOMIDE CHEMOTHERAPY EFFECTS ON GLIOMA PATIENT FERTILITY AND THEIR OFFSPRING: A RETROSPECTIVE REVIEW

被引：0
|
作者：
Lu, Austin [1 ,2 ,3 ]
Vu, Mia [1 ,2 ,3 ]
Schuman, Eva [1 ,2 ,3 ]
Ware, Cornelius [1 ,2 ,3 ]
Hsu, Sigmund [1 ,2 ,3 ]
Zhu, Jay-Jiguang [1 ,2 ,3 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, Dept Neurosurg, McGovern Med Sch, Houston, TX USA
[2] Mem Hermann Texas Med Ctr, Houston, TX USA
[3] Mem Hermann Hosp, Houston, TX USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae165.1036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
QLTI-22
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Downregulation of miR-196b Promotes Glioma Cell Sensitivity to Temozolomide Chemotherapy and Radiotherapy
    Ma, Ruimin
    Zheng, Guanghui
    Shao, Chunqing
    Liu, Jingzheng
    Lv, Hong
    Zhang, Guojun
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2018, 48 (06): : 719 - 725
  • [42] Salvage chemotherapy with temozolomide and CPT-11 for recurrent or progressive high-grade glioma
    Terasaki, Mizuhiko
    Fukushima, Shintaro
    Shigemori, Minoru
    NEURO-ONCOLOGY, 2007, 9 (04) : 526 - 526
  • [43] An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting
    Kyritsis, Athanassios P.
    Levin, Victor A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (05) : 971 - 983
  • [44] Impact of chemotherapy with Temozolomide on physiological brain 18F-DOPA uptake in patients with glioma
    Carideo, L.
    Cicone, F.
    Scaringi, C.
    Russo, I.
    Minniti, G.
    Scopinaro, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S298 - S298
  • [45] Prognostic value of MGMT methylation and expression in malignant glioma patients treated with adjuvant temozolomide chemotherapy
    Loeser, S. C.
    Blaschke, B.
    Koehler, S.
    Kreuzmann, A.
    Rapp, M.
    Goeppert, M.
    Reifenberger, G.
    Sabel, M.
    ACTA NEUROPATHOLOGICA, 2006, 112 (03) : 375 - 375
  • [46] A systematic review of amino acid PET in assessing treatment response to temozolomide in glioma
    Prather, Kiana Y.
    O'Neal, Christen M.
    Westrup, Alison M.
    Tullos, Hurtis J.
    Hughes, Kendall L.
    Conner, Andrew K.
    Glenn, Chad A.
    Battiste, James D.
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [47] Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis
    Yang, Qunying
    Guo, Chengcheng
    Lin, Xiaoping
    Luo, Lili
    He, Zhenqiang
    Lin, Fuhua
    Zhang, Ji
    Chen, Yinsheng
    Jiang, Xiaobing
    Ke, Chao
    Mou, Yonggao
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [48] Anlotinib plus temozolomide for recurrent glioma: A single-center, retrospective study of 30 cases
    Cao, Y.
    Xu, L.
    Tang, X.
    Li, Y.
    Yu, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S522 - S522
  • [49] Anlotinib alone or in combination with temozolomide in recurrent high-grade glioma: A retrospective study.
    Yang, Qun-ying
    Guo, Cheng-Cheng
    He, Zhenqiang
    Lin, Fuhua
    Zhang, Ji
    Guo, Xiaoyu
    Chen, Yinsheng
    Jiang, Xiaobing
    Ke, Chao
    Chen, Zhongping
    Mou, Yonggao
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study
    Taal, Walter
    Segers-van Rijn, Joyce M. W.
    Kros, Johan M.
    van Heuvel, Irene
    van der Rijt, Carin C. D.
    Bromberg, Jacoline E.
    Smitt, Peter A. E. Sillevis
    van den Bent, Martin J.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 108 (01) : 195 - 200
12345